Fundz

Fundz Deep Dive

Everything you need to win Aubrey C. Galloway — in one platform.

Who to reach, what to say, and why now on Aubrey C. Galloway — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Aubrey C. Galloway — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Cure Lab Oncology Names Dr. Aubrey C. Galloway As Chief Medical Officer

PRIVATEJul 11, 2024•almost 2 years ago

Position

Chief Medical Officer

Company

Curelab Oncology

Aubrey C. Galloway
DedhamBiotechnology

Description

CureLab Oncology has appointed Dr Aubrey C Galloway as chief medical officer, a strategic move following his recent addition to the company's scientific advisory board. Dr Galloway, a renowned cardiac surgeon and the Seymour Cohn Professor of Cardiothoracic Surgery at NYU Langone Health, brings extensive expertise in clinical trials, cardiovascular disease research, and an understanding of host inflammatory mediators of a variety of inflammatory diseases to this new position at CureLab Oncology.

Company Information

Company

Curelab Oncology

Location

417 GREENLODGE STREET

Dedham, Iowa, United States

About

CureLab Oncology Inc. is a clinical-stage biotech company headquartered in the greater Boston area, Massachusetts. CureLab is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab's lead investigational compound is code-named Elenagen, an experimental DNA therapy that consists of a circular piece of DNA called a plasmid that includes a gene for a human protein called p62/SQSTM1.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Curelab Oncology's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.